FDA Cites Aurobindo’s Sterile Drug Manufacturing Plant
By

By
The US Food and Drug Administration (FDA) has cited a sterile manufacturing plant of Aurobindo, a Hyderabad, India-headquartered generics and active pharmaceutical ingredients manufacturer, with nine observations. This follows an…

ST Pharm To Expand Oligonucleotide Manufacturing Capacity
By

By
ST Pharm, a Seoul, South Korea-based provider of nucleic acid manufacturing and development services, has announced an expansion of oligonucleotide manufacturing capacity. The company is constructing a new facility at…

Draper Designs Bioprocessing Device for CAR T-Cell Therapies
By

By
Draper, a Spiceland, Indiana-headquartered research and development company, has developed a microfluidic transduction device (MTD) for companies to manufacture T-cell therapies with less viral vectors, the delivery vehicle of genomic…

Recipharm, Altus Collaborate in Drug Delivery
By

By
Recipharm, a Jordbro, Sweden-based contract development and manufacturing organization, has signed a licensing agreement with Altus Formulation, a Quebec, Canada-headquartered drug formulation and development company, to access drug-delivery technologies and…

Biogen, AbbVie, Novo Nordisk, and Sanofi Lead Pipeline News
By

By
A roundup of the latest market developments from the pipelines of the pharmaceutical majors, featuring news from Biogen, AbbVie, Novo Nordisk, Sanofi, and Shire. Editor’s Note: This article was updated…

Takeda To Invest $30 million in New Cell-Therapy Mfg Facility in Dublin
By

By
Takeda Pharmaceutical Company plans to invest EUR 25 million ($30 million) to construct a new regenerative medicine facility at its site in Grange Castle, Dublin, Ireland. The investment will expand…

Novartis, Pear Therapeutics Partner in Digital Therapeutics
By

By
Novartis has partnered with Pear Therapeutics, a Boston, Massachusetts-based prescription digital therapeutics company, to develop prescription digital therapeutics using software applications designed to treat disease and improve clinical outcomes for…

Pall Biotech Opens Expanded Belgium Facility
By

By
Pall Corporation, a provider of filtration, separation, and purification products and services, has opened its expanded facility in Hoegaarden, Belgium after eight months of construction. The Hoegaarden facility expansion includes 2,000…

Catalent Completes $4.6-Million Expansion in Singapore
By

By
Catalent Pharma Solutions has completed a two-year, $4.6-million expansion at clinical-supply facility in Singapore.   The new expansion provides additional GMP space for secondary packaging, has doubled ambient storage, and…

Almac Group Completes $27.5-Million Expansion
By

By
Almac Group, a Craigavon, UK-based contract development and manufacturing organization, has opened a 95,000-square-foot cold-storage facility at its global headquarters in Northern Ireland. The facility represents the completion of a…